Yame Fabres Robaina Sancler-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yame Fabres Robaina Sancler-Silva has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Gabriel Augusto Monteiro
São Paulo State University (UNESP), School of Veterinary Medicine and Animal Science, Department of Veterinary Surgery and Animal Reproduction, Botucatu, São Paulo, Brazil
6 shared publications Cristian Silva Teixeira
Departament of Animal Science Federal University of Viçosa (UFV) Viçosa Minas Gerais Brazil
5 shared publicationsF.O. Papa
3 shared publicationsFrederico Ozanam Papa
3 shared publicationsC.P. Freitas-Dell’AQua
2 shared publicationsFernanda Saules Ignácio
2 shared publications
Latest Publications
- 12 October 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 167
Superior post-thaw sperm quality and fertility of epididymal compared with ejaculated sperm in subfertile stallions
- 12 October 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 167
Superior post-thaw sperm quality and fertility of epididymal compared with ejaculated sperm in subfertile stallions
- Open Access
- 8 September 2026
- Published by Wiley in Reproduction in Domestic Animals
- Vol. 61 (9) , e70318
Use of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Stallions: First Case Reports
Pharmacological aids can be useful alternatives to enhance penile erection and/or improve ejaculatory function, thereby prolonging the reproductive life of stallions with ejaculatory disorders. This study aimed to evaluate the effects of sildenafil citrate in the treatment of erectile dysfunction and on semen quality in two aged stallions, a Quarter Horse (18 years) and a Mangalarga Marchador (25 years), presented to the Veterinary Hospital of FMVZ‐UNESP, Botucatu, SP, Brazil. The treatment consisted of oral administration of sildenafil citrate at 0.2 mg/kg. Thirty minutes after administration, the Quarter Horse stallion achieved full erection and ejaculated in all collection attempts (100%; 3/3), with semen parameters within normal ranges for the species. The Mangalarga Marchador showed a partial response to treatment, with successful ejaculation in only one of three attempts (33.3%) and exhibited oligozoospermia, possibly associated with previously identified age‐related testicular degeneration concurrent with the erectile dysfunction. To the best of the authors' knowledge, this is the first report on the use of sildenafil citrate for managing erectile dysfunction in stallions, demonstrating its therapeutic potential. However, the results suggest individual variability in response to treatment, indicating the need for additional controlled studies to establish more precise dose–response protocols.
- 8 September 2026
- Published by Wiley in Reproduction in Domestic Animals
- Vol. 61 (9) , e70318
Open AccessUse of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Stallions: First Case Reports
Pharmacological aids can be useful alternatives to enhance penile erection and/or improve ejaculatory function, thereby prolonging the reproductive life of stallions with ejaculatory disorders. This study aimed to evaluate the effects of sildenafil citrate in the treatment of erectile dysfunction and on semen quality in two aged stallions, a Quarter Horse (18 years) and a Mangalarga Marchador (25 years), presented to the Veterinary Hospital of FMVZ‐UNESP, Botucatu, SP, Brazil. The treatment consisted of oral administration of sildenafil citrate at 0.2 mg/kg. Thirty minutes after administration, the Quarter Horse stallion achieved full erection and ejaculated in all collection attempts (100%; 3/3), with semen parameters within normal ranges for the species. The Mangalarga Marchador showed a partial response to treatment, with successful ejaculation in only one of three attempts (33.3%) and exhibited oligozoospermia, possibly associated with previously identified age‐related testicular degeneration concurrent with the erectile dysfunction. To the best of the authors' knowledge, this is the first report on the use of sildenafil citrate for managing erectile dysfunction in stallions, demonstrating its therapeutic potential. However, the results suggest individual variability in response to treatment, indicating the need for additional controlled studies to establish more precise dose–response protocols.
- Open Access
- 24 August 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 167
The adverse effects of testicular hyperthermia on semen quality in stallions are attenuated by oral pentoxifylline treatment
- 24 August 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 167
Open AccessThe adverse effects of testicular hyperthermia on semen quality in stallions are attenuated by oral pentoxifylline treatment
- Open Access
- 12 June 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 165, 106061
Post-AI uterine lavage and PRP infusion reduce some uterine inflammation parameters but do not improve fertility in jennies inseminated with frozen semen
- 12 June 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 165, 106061
Open AccessPost-AI uterine lavage and PRP infusion reduce some uterine inflammation parameters but do not improve fertility in jennies inseminated with frozen semen
- Open Access
- 29 May 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (5) , 664-671
Efficacy of 0.5% Tretinoin in the Treatment of Equine Aural Plaques
Background: Equine aural plaques are a benign form of auricular papillomatosis caused by equine papillomavirus. Despite the efficacy of 5% imiquimod cream, a marked local reaction is frequently observed during therapy, often requiring sedation before application. Hypothesis/Objectives: The aim of this study was to evaluate the efficacy and potential adverse effects of 0.5% topical tretinoin in the treatment of equine aural plaques. We hypothesised that tretinoin would be effective, with fewer adverse effects compared to imiquimod. Animals: The study included 10 horses of both sexes, aged between 7 months and 15 years, diagnosed with unilateral or bilateral aural plaques (totalling 17 ears). Materials and Methods: This was a controlled clinical trial. Three horses underwent a pilot study, in which only one ear per animal was treated to allow for intra‐animal comparison, while the remaining seven horses received treatment in both ears. Lesions were classified into three groups based on the percentage of the inner auricular surface affected. Treatment was performed with 0.5% topical tretinoin once daily until lesion stabilisation or resolution. Lesion characteristics, treatment response, adverse effects and recurrence were evaluated. Results: Sixty‐five percent of the ears exhibited an improvement of > 50% following treatment. On average, maximal lesion resolution occurred within 52.8 days (range 6–74 days). None of the horses exhibited severe sensitivity during the treatment period, allowing for ear manipulation throughout the study. Conclusions and Clinical Relevance: The topical application of 0.5% tretinoin cream proved to be an effective and safe treatment for equine aural plaques. Further studies with a larger sample size and long‐term follow‐up are recommended to optimise treatment protocols.
- 29 May 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (5) , 664-671
Open AccessEfficacy of 0.5% Tretinoin in the Treatment of Equine Aural Plaques
Background: Equine aural plaques are a benign form of auricular papillomatosis caused by equine papillomavirus. Despite the efficacy of 5% imiquimod cream, a marked local reaction is frequently observed during therapy, often requiring sedation before application. Hypothesis/Objectives: The aim of this study was to evaluate the efficacy and potential adverse effects of 0.5% topical tretinoin in the treatment of equine aural plaques. We hypothesised that tretinoin would be effective, with fewer adverse effects compared to imiquimod. Animals: The study included 10 horses of both sexes, aged between 7 months and 15 years, diagnosed with unilateral or bilateral aural plaques (totalling 17 ears). Materials and Methods: This was a controlled clinical trial. Three horses underwent a pilot study, in which only one ear per animal was treated to allow for intra‐animal comparison, while the remaining seven horses received treatment in both ears. Lesions were classified into three groups based on the percentage of the inner auricular surface affected. Treatment was performed with 0.5% topical tretinoin once daily until lesion stabilisation or resolution. Lesion characteristics, treatment response, adverse effects and recurrence were evaluated. Results: Sixty‐five percent of the ears exhibited an improvement of > 50% following treatment. On average, maximal lesion resolution occurred within 52.8 days (range 6–74 days). None of the horses exhibited severe sensitivity during the treatment period, allowing for ear manipulation throughout the study. Conclusions and Clinical Relevance: The topical application of 0.5% tretinoin cream proved to be an effective and safe treatment for equine aural plaques. Further studies with a larger sample size and long‐term follow‐up are recommended to optimise treatment protocols.
- Open Access
- 23 April 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 163, 105907
Application of 3D scanning for modeling and morphometric assessment of Mangalarga Marchador horses
- 23 April 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 163, 105907
Open AccessApplication of 3D scanning for modeling and morphometric assessment of Mangalarga Marchador horses
- Open Access
- 30 March 2026
- Published by Elsevier in Theriogenology
- Vol. 260, 117917
Comparative analysis of uterine inflammation in jennies and mares after insemination with cryopreserved donkey semen
- 30 March 2026
- Published by Elsevier in Theriogenology
- Vol. 260, 117917
Open AccessComparative analysis of uterine inflammation in jennies and mares after insemination with cryopreserved donkey semen
- 17 January 2026
- Published by Elsevier in Theriogenology
- Vol. 255, 117837
Doppler assessment of testicular arterial blood flow in stallions: influence of age and 180° spermatic cord torsion
- 17 January 2026
- Published by Elsevier in Theriogenology
- Vol. 255, 117837
Doppler assessment of testicular arterial blood flow in stallions: influence of age and 180° spermatic cord torsion
- Open Access
- 8 October 2025
- Published by Elsevier in Animal Reproduction Science
- Vol. 282, 108017
Eosinophils from jennies form extracellular traps (EETs) in vitro in response to seminal plasma: A new perspective on uterine immune defense in donkeys
- 8 October 2025
- Published by Elsevier in Animal Reproduction Science
- Vol. 282, 108017
Open AccessEosinophils from jennies form extracellular traps (EETs) in vitro in response to seminal plasma: A new perspective on uterine immune defense in donkeys